Published in Cell Mol Life Sci on September 01, 2006
Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol (2008) 1.97
Impaired placentation in fetal alcohol syndrome. Placenta (2007) 1.21
PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair. J Hepatol (2009) 1.20
Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. J Alzheimers Dis (2009) 1.15
Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. J Alzheimers Dis (2009) 1.07
Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration. Alcohol (2009) 1.04
GSK3beta in ethanol neurotoxicity. Mol Neurobiol (2009) 1.01
Alcohol exposure decreases CREB binding protein expression and histone acetylation in the developing cerebellum. PLoS One (2011) 1.00
The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids. Int J Environ Res Public Health (2009) 1.00
Ethanol-induced oxidative stress and mitochondrial dysfunction in rat placenta: relevance to pregnancy loss. Alcohol Clin Exp Res (2009) 0.97
Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication? Life Sci (2010) 0.95
In utero alcohol exposure, epigenetic changes, and their consequences. Alcohol Res (2013) 0.95
Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment. Mol Neurodegener (2009) 0.95
Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J Alzheimers Dis (2009) 0.94
Rat strain differences in susceptibility to alcohol-induced chronic liver injury and hepatic insulin resistance. Gastroenterol Res Pract (2010) 0.94
Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration. Alcohol Clin Exp Res (2008) 0.94
Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance. Hepatol Res (2011) 0.93
Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease. J Alzheimers Dis (2009) 0.91
Cyanidin-3-glucoside ameliorates ethanol neurotoxicity in the developing brain. J Neurosci Res (2011) 0.89
Mechanisms of ceramide-mediated neurodegeneration. J Alzheimers Dis (2009) 0.88
Role of central nervous system insulin resistance in fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol (2010) 0.88
High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism. Hepatol Res (2011) 0.88
Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function. Behav Brain Funct (2010) 0.86
Exposure of neonatal rats to alcohol has differential effects on neuroinflammation and neuronal survival in the cerebellum and hippocampus. J Neuroinflammation (2015) 0.85
Ethanol neurotoxicity in the developing cerebellum: underlying mechanisms and implications. Brain Sci (2013) 0.85
si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder. Mol Brain (2011) 0.83
Impaired insulin/IGF signaling in experimental alcohol-related myopathy. Nutrients (2012) 0.80
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art. Expert Opin Drug Deliv (2013) 0.79
Experimental alcohol-related peripheral neuropathy: role of insulin/IGF resistance. Nutrients (2012) 0.78
Prenatal ethanol exposure increases brain cholesterol content in adult rats. Lipids (2013) 0.77
Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain. Alcohol Alcohol (2015) 0.77
Dose effect of gestational ethanol exposure on placentation and fetal growth. Placenta (2015) 0.77
Sustained Impairments in Brain Insulin/IGF Signaling in Adolescent Rats Subjected to Binge Alcohol Exposures during Development. J Clin Exp Pathol (2012) 0.76
Prenatal Ethanol Exposure Up-Regulates the Cholesterol Transporters ATP-Binding Cassette A1 and G1 and Reduces Cholesterol Levels in the Developing Rat Brain. Alcohol Alcohol (2014) 0.76
Differential Contributions of Alcohol and the Nicotine-Derived Nitrosamine Ketone (NNK) to Insulin and Insulin-Like Growth Factor Resistance in the Adolescent Rat Brain. Alcohol Alcohol (2015) 0.76
Motor Function Deficits Following Chronic Prenatal Ethanol Exposure are Linked to Impairments in Insulin/IGF, Notch and Wnt Signaling in the Cerebellum. J Diabetes Metab (2013) 0.75
Mystic Acetaldehyde: The Never-Ending Story on Alcoholism. Front Behav Neurosci (2017) 0.75
A human genome diversity cell line panel. Science (2002) 14.11
Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol (1998) 4.21
Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics (1967) 3.60
Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60
THE CALORIGENETIC ACTION OF THYROXIN AT DIFFERENT LEVELS OF BASAL METABOLISM IN MYXEDEMA. J Clin Invest (1929) 3.22
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73
A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med (1991) 2.68
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 2.59
Hepatitis C virus: epidemiology and transmission. Hepatology (1997) 2.43
Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol (1986) 2.37
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology (1996) 2.18
Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med (1988) 2.17
The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest (1975) 2.13
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology (1975) 2.08
Osseointegrated implants for single tooth replacement in general practice: a 1-year report from a multicentre prospective study. Aust Dent J (1995) 2.05
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology (1998) 2.01
Pitfalls in current methods of CDH detection. J Paediatr Child Health (1991) 1.98
Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol (1997) 1.96
Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol (1998) 1.96
The increasing incidence of hepatocellular carcinoma. N Engl J Med (1999) 1.92
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
The native form and maturation process of hepatitis C virus core protein. J Virol (1998) 1.91
Primary hepatocellular carcinoma. N Engl J Med (1991) 1.91
Polynesian origins: insights from the Y chromosome. Proc Natl Acad Sci U S A (2000) 1.79
Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain (1991) 1.79
A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group. Hepatology (1999) 1.75
Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol (1978) 1.75
Rising incidence of breast cancer among young women in Washington State. J Natl Cancer Inst (1987) 1.74
Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med (1976) 1.68
The effect of age on the care of women with breast cancer in community hospitals. J Gerontol (1987) 1.65
Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology (2007) 1.64
Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals. Med Care (1989) 1.64
Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics (1991) 1.63
Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest (1975) 1.63
Dose-volume histograms. Int J Radiat Oncol Biol Phys (1991) 1.62
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol (1991) 1.61
Patterned distribution of metastases from malignant melanoma in humans. Cancer Res (1983) 1.60
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology (1997) 1.58
Hepatitis B transmission by dentists. JAMA (1974) 1.57
Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A (1978) 1.57
The secondary amine/nitric oxide complex ion R(2)N[N(O)NO](-) as nucleophile and leaving group in S9N)Ar reactions. J Org Chem (2001) 1.57
Intraosseous schwannoma: histologic features, ultrastructure, and review of the literature. Hum Pathol (1984) 1.57
Studying patterns of cancer care: how useful is the medical record? Am J Public Health (1988) 1.56
Quality of care in women with stage I cervical cancer. West J Med (1982) 1.55
The ltk receptor tyrosine kinase is expressed in pre-B lymphocytes and cerebral neurons and uses a non-AUG translational initiator. EMBO J (1990) 1.55
High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology (1981) 1.55
Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer (1984) 1.54
Cephalometric abnormalities in non-obese and obese patients with obstructive sleep apnoea. Eur Respir J (1999) 1.53
Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology (1997) 1.52
Time-course of recovery of gastric emptying and motility in rats with experimental spinal cord injury. Neurogastroenterol Motil (2009) 1.51
Infection of the retina by human immunodeficiency virus type I. N Engl J Med (1987) 1.50
Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A (1981) 1.48
Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. J Virol (1995) 1.48
Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol (1998) 1.44
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
The relation of obstetrical volume and nursery level to perinatal mortality. Am J Public Health (1990) 1.43
Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest (1996) 1.43
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci U S A (1998) 1.42
The transcriptional network controlling pluripotency in ES cells. Cold Spring Harb Symp Quant Biol (2008) 1.41
Fulminant hepatitis complicated by pancreatitis. Johns Hopkins Med J (1973) 1.40
Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med (1976) 1.39
Jehovah's Witnesses and surgery. Hong Kong Med J (2005) 1.39
Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology (1987) 1.39
Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res (2001) 1.38
Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest (1989) 1.37
Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J Biol Chem (1998) 1.34
NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des (2006) 1.31
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci (1997) 1.31
Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol (1997) 1.30
Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J Biol Chem (1994) 1.29
CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem (2000) 1.27
Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med (1985) 1.27
Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res (1997) 1.27
Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res (2000) 1.26
Coexpression of the homeobox genes Distal-less and homothorax determines Drosophila antennal identity. Development (2000) 1.25
Isolation, characterization, and distribution of an unusual pancreatic human secretory protein. J Clin Invest (1985) 1.24
Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology (1979) 1.24
Identification and characterization of a leukocyte-specific component of the nuclear body. J Biol Chem (1996) 1.24
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
Hepatitis B in an oncology unit. N Engl J Med (1974) 1.23
Monoclonal radioimmunoassays for hepatitis B surface antigen: demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes. Proc Natl Acad Sci U S A (1982) 1.23
Demonstration of previously undetected hepatitis B viral determinants in an Australian Aboriginal population by monoclonal anti-hbs antibody radioimmunoassays. Lancet (1982) 1.23
The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene. Proc Natl Acad Sci U S A (1992) 1.22
Monoclonal IgM radioimmunoassay for hepatitis B surface antigen: high binding activity in serum that is unreactive with conventional antibodies. Proc Natl Acad Sci U S A (1982) 1.22
Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology (1994) 1.21
Impaired placentation in fetal alcohol syndrome. Placenta (2007) 1.21
Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med (1976) 1.20
The effect of lower-extremity position on cerebrospinal fluid pressures. Acad Emerg Med (2001) 1.19
Automatic analysis of the EMG interference pattern. Electroencephalogr Clin Neurophysiol (1983) 1.19
Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest (2000) 1.19
Multiple origins of Tibetan Y chromosomes. Hum Genet (2000) 1.18
Sisters with polysplenia. Am J Med Genet (1985) 1.18
Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis (2008) 1.18